Medical Device | February 23, 2022
MicroLumix’ GermPass kills Covid-19 virus in five seconds
New biotechnology product aims to be world's fastest automatic sanitary solution
New biotechnology product aims to be world's fastest automatic sanitary solution
he financing was significantly oversubscribed with high demand from both existing and new investors.
Four additional AT2R agonists are expected to finalize preclinical evaluation during 2022
The COVID-19 pandemic has triggered the rapid growth of the biotherapeutics market
Prior to joining Biosion, Edwards was Vice President of Corporate Strategy and operations at Ionis Pharmaceuticals.
He will be responsible for developing the company's pipeline of partnered and in-house discovery programs,
New inhalers would have near-zero Global Warming Potential propellant
The sale is expected to close in the first quarter of 2022
Dr. Reddy’s, will focus its resources and capabilities on its key therapy spaces of gastroenterology, pain management, cold and flu, allergy, oncology, neurology, paediatrics and women’s health as the Russia and CIS region continues to be a strong performer for the company
According to the Indian Journal of Medical Research in 2018, the estimated prevalence of pre-diabetes in India is 14%, which means that one out of six Indians is pre-diabetic
Subscribe To Our Newsletter & Stay Updated
